Researchers have employed R6/1 and R6/2 transgenic mice, carrying mutations in the human HTT gene that lead to slow and rapid progression of HD symptoms, respectively, to study HD-associated retinal pathology. The gene discussed is HTT; the disease is Huntington disease.